ArticleScientific reports2025
Hmox1 expression indicates distinct injury phenotypes of proximal tubule cells in sepsis-associated acute kidney injury.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Sepsis-associated acute kidney injury (SAKI) is the most common organ dysfunction in sepsis and a significant contributor to high mortality rates. Despite its clinical importance, the underlying pathogenesis of SAKI remains unclear, and effective therapies are currently lacking. This study aims to identify specific biomarkers for SAKI diagnosis by integrating bulk and single-cell RNA sequencing data from renal tissues in the SAKI model. We analyzed changes in mRNA/protein expression and cellular localization in kidney tissues affected by SAKI and confirmed that Hmox1 has potential as an indicator of proximal tubule (PT) injury in SAKI. Further validation across mouse models, and patient samples confirmed the role of Hmox1 in SAKI. Notably, we observed that Hmox1 high- and low-expressing PT cell subsets exhibit distinct phenotypes in SAKI. The Hmox1
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.